We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+17.95%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.16%
AUM
$10.2B
AUM Growth
+$1.96B
Cap. Flow
+$643M
Cap. Flow %
6.28%
Top 10 Hldgs %
43.19%
Holding
1,081
New
132
Increased
418
Reduced
456
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 26.61%
2 Financials 16.65%
3 Industrials 3.29%
4 Energy 3.1%
5 Consumer Discretionary 2.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMM icon
476
3M
MMM
$93.9B
$1.13M 0.01%
7,721
+1,690
+28% +$240K
SPG icon
477
Simon Property Group
SPG
$72.9B
$1.1M 0.01%
12,862
+774
+6% +$59.1K
KOD icon
478
Kodiak Sciences
KOD
$2.73B
$1.09M 0.01%
7,410
-19,941
-73% -$2.22M
EW icon
479
Edwards Lifesciences
EW
$51.3B
$1.09M 0.01%
11,928
-30,655
-72% -$2.54M
DOOR
480
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$1.08M 0.01%
11,001
-2,462
-18% -$239K
BBIO icon
481
BridgeBio Pharma
BBIO
$16.1B
$1.08M 0.01%
15,196
-29,059
-66% -$1.4M
APLS
482
DELISTED
Apellis Pharmaceuticals
APLS
$1.07M 0.01%
18,759
-50,470
-73% -$2.13M
EDIT icon
483
Editas Medicine
EDIT
$422M
$1.06M 0.01%
15,055
-51,104
-77% -$2.1M
WY icon
484
Weyerhaeuser
WY
$18.6B
$1.05M 0.01%
31,410
+1,419
+5% +$42.7K
WELL icon
485
Welltower
WELL
$171B
$1.05M 0.01%
16,212
+156
+1% +$9.47K
ARNA
486
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.03M 0.01%
13,474
-17,836
-57% -$1.34M
BMRN icon
487
BioMarin Pharmaceuticals
BMRN
$11.6B
$1.03M 0.01%
11,728
-50,828
-81% -$4.03M
HUM icon
488
Humana
HUM
$43.7B
$1.03M 0.01%
2,502
-199
-7% -$82.7K
UTHR icon
489
United Therapeutics
UTHR
$22B
$1.02M 0.01%
6,722
-12,633
-65% -$1.66M
AGO icon
490
Assured Guaranty
AGO
$3.66B
$1.02M 0.01%
32,354
+4,512
+16% +$133K
KAMN
491
DELISTED
Kaman Corp
KAMN
$1.01M 0.01%
17,692
+765
+5% +$37.6K
BTAI icon
492
BioXcel Therapeutics
BTAI
$26M
$999K 0.01%
1,352
-1,408
-51% -$1.1M
LGND icon
493
Ligand Pharmaceuticals
LGND
$6.06B
$999K 0.01%
16,096
-15,158
-48% -$864K
EBS icon
494
Emergent Biosolutions
EBS
$389M
$998K 0.01%
11,139
-9,092
-45% -$834K
QURE icon
495
uniQure
QURE
$3.07B
$996K 0.01%
+27,555
New +$1.16M
GBT
496
DELISTED
Global Blood Therapeutics, Inc.
GBT
$995K 0.01%
22,978
-14,629
-39% -$721K
NBIX icon
497
Neurocrine Biosciences
NBIX
$16.4B
$991K 0.01%
10,334
-9,432
-48% -$911K
BECN
498
DELISTED
Beacon Roofing Supply, Inc.
BECN
$983K 0.01%
24,467
-5,442
-18% -$199K
CDNA icon
499
CareDx
CDNA
$2.35B
$980K 0.01%
13,522
-35,856
-73% -$2.08M
R icon
500
Ryder
R
$10.2B
$978K 0.01%
15,834
+5,745
+57% +$320K

Similar funds

Rafferty Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Rafferty Asset Management held 1,081 positions worth $10.2B, up 24% from $8.27B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Rafferty Asset Management deployed $643M of net new capital in Q4 2020, opening 132 new positions and adding to 418 existing holdings. Its largest new stake was Keurig Dr Pepper: 119,771 shares worth $3.83M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P Oil & Gas Exploration & Production ETF, an estimated $92.8M trimmed.

  • Rafferty Asset Management's largest Q4 2020 buy was Keurig Dr Pepper: 119,771 shares worth $3.83M.
  • Rafferty Asset Management added most to iShares Russell 2000 ETF in Q4 2020, an estimated $264M increase.
  • Rafferty Asset Management's biggest Q4 2020 reduction was State Street SPDR S&P Oil & Gas Exploration & Production ETF, cutting an estimated $92.8M.
  • Rafferty Asset Management fully exited iShares MSCI EAFE ETF in Q4 2020, selling an estimated $4.41M.
  • Rafferty Asset Management's ten largest holdings make up 43% of its $10.2B portfolio in Q4 2020.
  • Rafferty Asset Management opened 132 new positions and closed 74 in Q4 2020.
  • Rafferty Asset Management's portfolio value rose 24% quarter-over-quarter to $10.2B.

Based on Rafferty Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.